Terms: = Skin cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Clinical Outcome
9 results:
1. A Randomized Controlled Pilot Study: Combined 595-nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea.
Sodha P; Suggs A; Munavalli GS; Friedman PM
Lasers Surg Med; 2021 Dec; 53(10):1307-1315. PubMed ID: 34233378
[TBL] [Abstract] [Full Text] [Related]
2. Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition.
Litchfield K; Reading JL; Puttick C; Thakkar K; Abbosh C; Bentham R; Watkins TBK; Rosenthal R; Biswas D; Rowan A; Lim E; Al Bakir M; Turati V; Guerra-Assunção JA; Conde L; Furness AJS; Saini SK; Hadrup SR; Herrero J; Lee SH; Van Loo P; Enver T; Larkin J; Hellmann MD; Turajlic S; Quezada SA; McGranahan N; Swanton C
Cell; 2021 Feb; 184(3):596-614.e14. PubMed ID: 33508232
[TBL] [Abstract] [Full Text] [Related]
3. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation.
Chen A; Santana AL; Doudican N; Roudiani N; Laursen K; Therrien JP; Lee J; Felsen D; Carucci JA
PLoS One; 2020; 15(11):e0241551. PubMed ID: 33227008
[TBL] [Abstract] [Full Text] [Related]
4. Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial.
Brøndum L; Alsner J; Sørensen BS; Maare C; Johansen J; Primdahl H; Evensen JF; Kristensen CA; Andersen LJ; Overgaard J; Eriksen JG
Acta Oncol; 2018 Sep; 57(9):1159-1164. PubMed ID: 29771169
[TBL] [Abstract] [Full Text] [Related]
5. [Biological role and prognostic significance of genetic alterations in human malignant melanomas].
Vízkeleti L
Magy Onkol; 2015 Sep; 59(3):268-72. PubMed ID: 26339916
[TBL] [Abstract] [Full Text] [Related]
6. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract] [Full Text] [Related]
7. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
[TBL] [Abstract] [Full Text] [Related]
8. Mechanisms of egfr gene transcription modulation: relationship to cancer risk and therapy response.
Brandt B; Meyer-Staeckling S; Schmidt H; Agelopoulos K; Buerger H
Clin Cancer Res; 2006 Dec; 12(24):7252-60. PubMed ID: 17189396
[TBL] [Abstract] [Full Text] [Related]
9. Molecular determinants of cetuximab efficacy.
Vallböhmer D; Zhang W; Gordon M; Yang DY; Yun J; Press OA; Rhodes KE; Sherrod AE; Iqbal S; Danenberg KD; Groshen S; Lenz HJ
J Clin Oncol; 2005 May; 23(15):3536-44. PubMed ID: 15908664
[TBL] [Abstract] [Full Text] [Related]
